Traumatic Injury

Use of radiographic fracture displacement to guide surgical and clinical decision-making may yield excellent functional outcomes and comparable complication rates among pediatric patients with lateral condyle fractures, according to results.

The American Academy of Orthopaedic Surgeons announced Marc F. Swiontkowski, MD, FAAOS, has received the Kappa Delta Ann Doner Vaughn Award for research he and his colleagues conducted into outcomes after operative treatment of femoral neck fractures.

Published results showed either internal or external fixation after lateral closing-wedge corrective osteotomy yielded reliable outcomes with a low rate of complications and satisfactory functional results in pediatric patients with cubitus varus.

Implementation of a fracture liaison service program may lead to effective treatment for osteoporosis among patients with fragility fractures of the hip, according to results.

In a retrospective review, researchers found use of bipolar and press-fit implants in hemiarthroplasty for treatment of hip fractures increased construct costs and had little evidence of improved outcomes compared with the use of cemented monopolar implants.

Use of DEXA scan alone may not adequately identify patients with hip fracture at risk for fragility fracture, according to results.

The Kappa Delta Young Investigator Award, for researchers younger than age 40 years who have presented outstanding research in musculoskeletal disease or injury, has been given to Alice Huang, PhD for her study on tendon development and healing.

Patients in the pre-collapse stages of post-traumatic osteonecrosis of the femoral head may receive safe and effective treatment with platelet-rich plasma-incorporated autologous granular bone grafting, according to published results.

Use of a low-cost negative pressure wound therapy system may be an effective and safe alternative compared with commercially available negative pressure wound therapy systems in a resource-challenged setting, according to results.

OrthoGrid Systems Inc. received FDA 510(k) clearance for the PhantomMSK Trauma application.